Allan I. Levey
Affiliations: | Emory University, Atlanta, GA |
Google:
"Allan Levey"Mean distance: 16.01 (cluster 11)
Children
Sign in to add traineeEvan P. Lebois | grad student | Emory | |
Scott E. Counts | grad student | 2000 | Emory |
Oren A. Levy | grad student | 2001 | Emory |
Jennifer L. Berkeley | grad student | 2002 | Emory |
Laura A. Volpicelli-Daley | grad student | 2003 | Emory |
Daniel B. McClatchy | grad student | 2004 | Emory |
Leah R. Anderson | grad student | 2007 | Emory |
Katrin Offe | grad student | 2007 | Emory |
Albert A. Davis | grad student | 2009 | Emory |
Yair M. Gozal | grad student | 2009 | Emory |
Sruti Rayaprolu | post-doc | 2018- | Emory University School of Medicine |
Gary W. Miller | post-doc | 1995-1997 | Emory University School of Medicine |
Syed Ali Raza | post-doc | 2016-2018 | |
William T. Hu | research scientist | Emory |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Levites Y, Dammer EB, Ran Y, et al. (2024) Integrative proteomics identifies a conserved Aβ amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer's disease. Cell Reports. Medicine. 101669 |
Wojtas AM, Dammer EB, Guo Q, et al. (2024) Proteomic changes in the human cerebrovasculature in Alzheimer's disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluid. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
Wojtas AM, Dammer EB, Guo Q, et al. (2024) Proteomic Changes in the Human Cerebrovasculature in Alzheimer's Disease and Related Tauopathies Linked to Peripheral Biomarkers in Plasma and Cerebrospinal Fluid. Medrxiv : the Preprint Server For Health Sciences |
Johnson ECB, Bian S, Haque RU, et al. (2023) Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease. Nature Medicine |
Wynne ME, Ogunbona O, Lane AR, et al. (2023) APOE expression and secretion are modulated by mitochondrial dysfunction. Elife. 12 |
Ehrenberg AJ, Kelberman MA, Liu KY, et al. (2023) Priorities for research on neuromodulatory subcortical systems in Alzheimer's disease: Position paper from the NSS PIA of ISTAART. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
Del Campo M, Peeters CFW, Johnson ECB, et al. (2022) CSF proteome profiling across the Alzheimer's disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels. Nature Aging. 2: 1040-1053 |
Chan AWS, Cho IK, Li CX, et al. (2022) Cerebral Aβ deposition in an Aβ-precursor protein-transgenic rhesus monkey. Aging Brain. 2 |
Rayaprolu S, Bitarafan S, Santiago JV, et al. (2022) Cell type-specific biotin labeling in vivo resolves regional neuronal and astrocyte proteomic differences in mouse brain. Nature Communications. 13: 2927 |
Levey AI, Qiu D, Zhao L, et al. (2021) A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment. Brain : a Journal of Neurology |